101 related articles for article (PubMed ID: 3350997)
21. Negative correlation between alpha-1-acid-glycoprotein plasma level and response to haloperidol in the acute treatment of schizophrenia.
Levinson I; Levine S
Biol Psychiatry; 1995 Aug; 38(3):198-200. PubMed ID: 7578667
[No Abstract] [Full Text] [Related]
22. The assessment and clinical implications of haloperidol acute-dose, steady-state, and withdrawal pharmacokinetics.
Khot V; DeVane CL; Korpi ER; Venable D; Bigelow LB; Wyatt RJ; Kirch DG
J Clin Psychopharmacol; 1993 Apr; 13(2):120-7. PubMed ID: 8463444
[TBL] [Abstract][Full Text] [Related]
23. Coadministration of fluvoxamine increases serum concentrations of haloperidol.
Daniel DG; Randolph C; Jaskiw G; Handel S; Williams T; Abi-Dargham A; Shoaf S; Egan M; Elkashef A; Liboff S
J Clin Psychopharmacol; 1994 Oct; 14(5):340-3. PubMed ID: 7806690
[TBL] [Abstract][Full Text] [Related]
24. Haloperidol. Plasma levels and prolactin response as predictors of clinical improvement in schizophrenia: chemical v radioreceptor plasma level assays.
Smith RC; Baumgartner R; Misra CH; Mauldin M; Shvartsburd A; Ho BT; DeJohn C
Arch Gen Psychiatry; 1984 Nov; 41(11):1044-9. PubMed ID: 6497566
[TBL] [Abstract][Full Text] [Related]
25. Serum haloperidol concentration and clinical response in schizophrenia.
Kirch DG; Bigelow LB; Korpi ER; Wagner RL; Zalcman S; Wyatt RJ
Schizophr Bull; 1988; 14(2):283-9. PubMed ID: 3201181
[TBL] [Abstract][Full Text] [Related]
26. Haloperidol and reduced haloperidol serum levels: correlation with psychopathology in acute schizophrenia.
Stevens A; Mahal A; Gaertner HJ
Pharmacopsychiatry; 1992 Sep; 25(5):218-23. PubMed ID: 1409866
[TBL] [Abstract][Full Text] [Related]
27. Intensive treatment with haloperidol of treatment-resistant chronic schizophrenic patients.
Hollister LE; Kim DY
Am J Psychiatry; 1982 Nov; 139(11):1466-8. PubMed ID: 7137396
[TBL] [Abstract][Full Text] [Related]
28. Plasma haloperidol levels and therapeutic response in acute mania and schizophrenia.
Balant-Gorgia AE; Eisele R; Balant L; Garrone G
Eur Arch Psychiatry Neurol Sci; 1984; 234(1):1-4. PubMed ID: 6489392
[TBL] [Abstract][Full Text] [Related]
29. Serum haloperidol and neuroleptic receptor levels in chronic psychosis.
Cannon DJ; McMillan DE; Newton JE; Fody EP; Metzer WS; Claybrook M; Couch L; Paige SR
Ann Clin Lab Sci; 1988; 18(5):378-83. PubMed ID: 3178137
[TBL] [Abstract][Full Text] [Related]
30. Haloperidol plasma levels and clinical response: a therapeutic window relationship.
Van Putten T; Marder SR; Mintz J; Poland RE
Am J Psychiatry; 1992 Apr; 149(4):500-5. PubMed ID: 1554036
[TBL] [Abstract][Full Text] [Related]
31. Disposition of haloperidol pyridinium and reduced haloperidol pyridinium in schizophrenic patients: no relationship with clinical variables during short-term treatment.
Ulrich S; Neuhof S; Braun V; Danos P; Pester U; Hoy L
J Clin Psychopharmacol; 2000 Apr; 20(2):210-9. PubMed ID: 10770460
[TBL] [Abstract][Full Text] [Related]
32. Determination of plasma haloperidol concentrations by radioreceptor assay in schizophrenia: clinical utility.
Santos JL; Ramos JA; Prieto P; Almoguera I; Vazquez C; Rubio ME; Cabranes JA
Prog Neuropsychopharmacol Biol Psychiatry; 1989; 13(6):917-25. PubMed ID: 2813809
[TBL] [Abstract][Full Text] [Related]
33. Comparative efficacy of red cell and plasma haloperidol as predictors of clinical response in schizophrenia.
Smith RC; Baumgartner R; Shvartsburd A; Ravichandran GK; Vroulis G; Mauldin M
Psychopharmacology (Berl); 1985; 85(4):449-55. PubMed ID: 2862652
[TBL] [Abstract][Full Text] [Related]
34. Plasma clozapine and haloperidol concentrations in adolescents with childhood-onset schizophrenia: association with response.
Piscitelli SC; Frazier JA; McKenna K; Albus KE; Grothe DR; Gordon CT; Rapoport JL
J Clin Psychiatry; 1994 Sep; 55 Suppl B():94-7. PubMed ID: 7961584
[TBL] [Abstract][Full Text] [Related]
35. The relationship between haloperidol blood levels and clinical responses.
Itoh H; Yagi G; Fujii Y; Iwamura K; Ichikawa K
Prog Neuropsychopharmacol Biol Psychiatry; 1984; 8(2):285-92. PubMed ID: 6539935
[TBL] [Abstract][Full Text] [Related]
36. Lack of significant pharmacokinetic interaction between haloperidol and grapefruit juice.
Yasui N; Kondo T; Suzuki A; Otani K; Mihara K; Furukori H; Kaneko S; Inoue Y
Int Clin Psychopharmacol; 1999 Mar; 14(2):113-8. PubMed ID: 10220126
[TBL] [Abstract][Full Text] [Related]
37. Serum level monitoring and therapeutic effect of haloperidol in schizophrenic patients.
Moulin MA; Davy JP; Debruyne D; Andersson JC; Bigot MC; Camsonne R; Poilpré E
Psychopharmacology (Berl); 1982; 76(4):346-50. PubMed ID: 6812109
[TBL] [Abstract][Full Text] [Related]
38. Reduced haloperidol plasma concentration and clinical response in acute exacerbations of schizophrenia.
Kelly MW; Perry PJ; Coryell WH; Miller DD; Arndt SV
Psychopharmacology (Berl); 1990; 102(4):514-20. PubMed ID: 2096408
[TBL] [Abstract][Full Text] [Related]
39. Total and free plasma neuroleptic levels in schizophrenic patients.
Tang SW; Glaister J; Davidson L; Toth R; Jeffries JJ; Seeman P
Psychiatry Res; 1984 Dec; 13(4):285-93. PubMed ID: 6596586
[TBL] [Abstract][Full Text] [Related]
40. Clinical response and plasma haloperidol levels in chronic and subchronic schizophrenia.
Santos JL; Cabranes JA; Vazquez C; Fuentenebro F; Almoguera I; Ramos JA
Biol Psychiatry; 1989 Aug; 26(4):381-8. PubMed ID: 2669981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
